Therefore, whether Kindlin-3 expression by stromal cells might contribute to tumor progression in the same way as demonstrated for Kindlin-2 in pancreatic and bladder cancers [22] worth further investigations. This evidence concerns the gene FERMT3 and urinary bladder carcinoma.